Aptar PharmaProduct InfoFirst Nasally-Administered Pharmaceutical Treatment for Dry Eye Disease Approved by US FDA with Aptar’s Nasal Pump SystemAptar Pharma’s patented Cartridge Pump System (CPS), was recently reviewed by the U.S. FDA as the dr...
Aptar PharmaProduct InfoAptar Pharma's nasal unidose device approved for Tosymra sumatriptan sprayAptar Pharma, a leading provider of drug delivery devices worldwide and part of AptarGroup, Inc. has...
Aptar PharmaCompany NewsAptar Pharma's bidose nasal drug delivery device approved by US FDA for breakthrough treatment of depressionAptar Pharma, a leading drug delivery systems provider, has announced that its Bidose nasal spray de...
Aptar PharmaProduct InfoAptar Pharma provides unit-dose nasal spray technology for treatment of opioid overdoseAptar Pharma has announced that it has provided the delivery system and regulatory support for Adap...